Search ASX code:
Generic filters

Search ASX code:
Generic filters

Search ASX code:
Generic filters

This year. We're going Beyond.

Premier Investments (ASX:PMV) shares are going nuts

The Premier Investments Limited (ASX: PMV) share price is up over 10% after the retailer gave an update.

Premier Investments sells products through a number of brands including Smiggle, Jay Jays, Just Jeans, Peter Alexander and Dotti.

Premier Investment trading update

The company has given an update for the 26 weeks ending 25 July 2020, being its FY20 second half.

Premier Investments said that global sales were $484.2 million which was down $106.5 million or 18% on the second half of FY19.

However, despite the headline drop in sales and related decline in gross profit. Premier’s online sales and EBIT growth (click here to learn what EBIT means) continued to accelerate and deliver record earnings according to the company.

The company saw online sales of $123.3 million in the second half, up 70% compared to the prior corresponding period. Online sales made up around a quarter of Premier Retail’s total sales. The online sales deliver a “significantly” higher EBIT margin than the EBIT margin of the retail store network.

Profit expectations

Premier Retail is now expecting FY20 second half EBIT to be between $58.7 million to $59.7 million. This would be growth of 9.7% to 11.7%.

Therefore, FY20 EBIT is now expected to be between $184.8 million and $185.8 million – up 10.5% and 11%.

Summary

It’s impressive that Premier Investments has done so well during this period despite its store network shutting. I think it shows the benefit of having really good retail websites so that customers can continue to shop.

I believe that Premier Investments is one of the best ASX retail shares. However, I’m not sure how much of this growth is due to stimulus – 2021 will be very interesting! With the strength of the Premier Investment share price recovery, I think there are other ASX growth shares and ASX dividend shares I’d rather buy first.

Got $1,000? Try our #1 growth stock...

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or enter your email below. We'll send you the report.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Got $1,000? Try this...

Rask's top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond. This is a SERIOUS growth stock.

CLICK HERE to get the ASX stock ticker code, 3,500-word analysis and ASX founder interview!

Our expert investment reports are 100% free.

Simply click here or the button below. We'll email you the report.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Keep reading: